Position in AKTS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$30,710,162
+$13,663,783 QoQ
Shares Held
952,844
0.0% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
5.83%
of 13F equity value
Holder Rank
#12
of 114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AKTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Merck & Co., Inc. holds $338,204,928 across 12 Biotechnology names. AKTS ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
2,308,190 | $161,642,545 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
772,165 | $88,544,160 | |
| 3 | AKTS |
Aktis Oncology, Inc.
This page
|
952,844 | $30,710,162 | |
| 4 | EIKN |
Eikon Therapeutics, Inc.
|
1,666,666 | $21,749,991 | |
| 5 | TRDA |
Entrada Therapeutics, Inc.
|
1,739,768 | $12,804,692 | |
| 6 | STRO |
Sutro Biopharma, Inc.
|
272,351 | $9,042,053 | |
| 7 | ALEC |
Alector, Inc.
|
3,545,719 | $7,126,895 | |
| 8 | EVAX |
Evaxion A/S
|
1,214,126 | $3,763,790 |
All Filings in AKTS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,710,162 | 952,844 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $17,046,379 | 952,844 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||